OncoCyte Corporation (OCX)

Nov 15, 2024

Seasoned Financial executive joins Oncocyte as CFO - Reuters.com

Nov 15, 2024

Nov 14, 2024

PURA VIDA INVESTMENTS, LLC Expands Stake in OncoCyte Corp - GuruFocus.com

Nov 14, 2024

Nov 13, 2024

OncoCyte stock maintains Buy rating with Needham after GraftAssure RUO launch - Investing.com

Nov 13, 2024

Nov 13, 2024

OncoCyte Corporation (NASDAQ:OCX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 13, 2024

OncoCyte: Q3 Earnings Snapshot - Darien Times

Nov 13, 2024

Nov 13, 2024

OncoCyte Corp (OCX) Q3 2024 Earnings Call Highlights: Progress i - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

OncoCyte Corp (OCX) Q3 2024 Earnings Call Highlights: Progress in Transplant Testing and ... - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

OncoCyte Corp Reports Q3 2024 Earnings and Strategic Updates - TipRanks

Nov 12, 2024

Nov 12, 2024

OncoCyte Corp (OCX) Q3 2024 Earnings: EPS of -$0.98 Misses Estimates, Revenue Falls Short at $115,000 - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025 - The Manila Times

Nov 12, 2024

Nov 12, 2024

Oncocyte Corporation (OCX) Quarterly 10-Q Report - Quartz

Nov 12, 2024

Nov 11, 2024

What to Expect from OncoCyte's Earnings - Benzinga

Nov 11, 2024

Nov 06, 2024

Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12 - ForexTV.com

Nov 06, 2024

Nov 02, 2024

OncoCyte (NASDAQ:OCX) Coverage Initiated by Analysts at StockNews.com - MarketBeat

Nov 02, 2024

Oct 27, 2024

StockNews.com Initiates Coverage on OncoCyte (NASDAQ:OCX) - MarketBeat

Oct 27, 2024

Oct 17, 2024

Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles - The Manila Times

Oct 17, 2024

Oct 16, 2024

Oncocyte Corp expands equity incentive plan - Investing.com India

Oct 16, 2024

Oct 16, 2024

Oncocyte Corp expands equity incentive plan By Investing.com - Investing.com Australia

Oct 16, 2024

Oct 16, 2024

OncoCyte shares maintain Buy rating from Needham By Investing.com - Investing.com Nigeria

Oct 16, 2024

Oct 15, 2024

OncoCyte shares maintain Buy rating from Needham - Investing.com

Oct 15, 2024

Oct 09, 2024

OncoCyte Corp (OCX) Q2 2024 Earnings Call Highlights: Strategic Advances Amidst Financial Challenges - Yahoo Finance

Oct 09, 2024

Oct 08, 2024

Oncocyte reports breakthrough in breast cancer diagnostics - Investing.com

Oct 08, 2024

Oct 08, 2024

Oncocyte's DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial - The Manila Times

Oct 08, 2024

Oct 08, 2024

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial - StockTitan

Oct 08, 2024

Oct 05, 2024

Broadwood Partners L.P. buys Oncocyte shares for $3.88 million By Investing.com - Investing.com Australia

Oct 05, 2024

Oct 04, 2024

Oncocyte CFO acquires $99,999 worth of company shares By Investing.com - Investing.com South Africa

Oct 04, 2024

Oct 04, 2024

Oncocyte CFO acquires $99,999 worth of company shares - Investing.com

Oct 04, 2024

Oct 04, 2024

Broadwood Partners L.P. buys Oncocyte shares for $3.88 million - Investing.com

Oct 04, 2024

Oct 04, 2024

OncoCyte Secures Funding Through Private Share Sale - Yahoo Finance

Oct 04, 2024

Oct 03, 2024

OncoCyte Corporation announced that it expects to receive $10.203435 million in funding from Bio-Rad Laboratories, Inc. - Marketscreener.com

Oct 03, 2024

Oct 03, 2024

LENSAR reports inducement grants - Medical Buyer

Oct 03, 2024

Oct 03, 2024

Oncocyte Corporation enters into securities purchase agreement - Medical Buyer

Oct 03, 2024

Oct 03, 2024

Oncocyte Signs Leading Transplant Centers in US and Germany - The Manila Times

Oct 03, 2024

Oct 02, 2024

Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules - ForexTV.com

Oct 02, 2024

Oct 02, 2024

Sandfire Resources America Inc. Announces Incentive Plan Grants - The Manila Times

Oct 02, 2024